These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10422456)

  • 1. [Pulmonary thromboembolism in a female with resistance to activated protein C].
    Ribeiro A; Correia A; Fernandes F; Barbosa AP; Basto L; Lima F; Rodrigues P
    Rev Port Cardiol; 1999 Jun; 18(6):601-7. PubMed ID: 10422456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
    Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C resistance, factor V Leiden and assessment of thrombotic risk.
    Gilmore R; Doyle M; Holden F; White B; O'Donnell J
    Ir Med J; 2008 Sep; 101(8):256-7. PubMed ID: 18990960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired activated protein C resistance, high tissue factor expression, and hyper-homocysteinemia in systemic lupus erythematosus.
    Oh D; Kim SH; Kang MS; Kim NK; Chang NS; Na BW; Chung SY; Park S; Cho CS
    Am J Hematol; 2003 Feb; 72(2):103-8. PubMed ID: 12555213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [National evaluation of the diagnosis of activated protein C resistance].
    Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R
    Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycoplasma pneumonia and pulmonary embolism in a child due to acquired prothrombotic factors.
    Brown SM; Padley S; Bush A; Cummins D; Davidson S; Buchdahl R
    Pediatr Pulmonol; 2008 Feb; 43(2):200-2. PubMed ID: 18041082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between phenomenon of acquired activated protein C resistance and antiphospholipid antibodies in patients with systemic lupus erythematosus].
    Hu YQ; Chen FP; Xie QZ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):469-72. PubMed ID: 12536506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activated protein C resistance (APCR) in thromboembolic diseases in Cotonou (Benin)].
    Kouassil D; Diafouka F; Djima M; Zohoun I; Adoh A; Monnet D; Agboton H; Sangare A
    Ann Biol Clin (Paris); 2004; 62(2):246-7. PubMed ID: 15047482
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated protein C resistance is uncommon in sudden death due to pulmonary embolism.
    Rulon JJ; Cho CG; Guerra LL; Bux RC; Gulley ML
    J Forensic Sci; 1999 Nov; 44(6):1111-3. PubMed ID: 10582351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
    Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary embolism disclosing activated protein C resistance].
    Strecker A; Bernardi F; Wolschies E; Hendricx S; Jude B
    Rev Mal Respir; 1996 Oct; 13(5):521-2. PubMed ID: 8999481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C resistance in cord blood from healthy and complicated newborns.
    Gursel T; Kocak U; Kaya Z; Bukulmez A; Atalay Y
    J Matern Fetal Neonatal Med; 2007 Nov; 20(11):797-801. PubMed ID: 17853185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk?
    André E; Hacquard M; Alnot Y; de Maistre E; Lecompte T
    Thromb Haemost; 2007 Sep; 98(3):693-4. PubMed ID: 17849066
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.
    Elice F; Fink L; Tricot G; Barlogie B; Zangari M
    Br J Haematol; 2006 Aug; 134(4):399-405. PubMed ID: 16882132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic complications after spinal surgery in trauma patients.
    Platzer P; Thalhammer G; Jaindl M; Obradovic A; Benesch T; Vecsei V; Gaebler C
    Acta Orthop; 2006 Oct; 77(5):755-60. PubMed ID: 17068706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of resistance to activated protein C in myocardial infarction patients].
    Avellone G; Di Garbo V; Di Raimondo D; Bono M; Abruzzese G; De Simone R; Raneli G
    Minerva Cardioangiol; 2001 Dec; 49(6):363-8. PubMed ID: 11733730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors of venous thromboembolism].
    Barczyk A; Pierzchała W
    Wiad Lek; 2001; 54(5-6):311-24. PubMed ID: 11556214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and activated protein C resistance.
    Solá E; Vayá A; Villa P; España F; Estellés A; García K; Hernández-Mijares A
    Pathophysiol Haemost Thromb; 2008; 36(2):64-8. PubMed ID: 19127084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.